dc.contributor.author |
Gotuzzo Herencia, José Eduardo |
|
dc.contributor.author |
Seas Ramos, Carlos Rafael |
|
dc.contributor.author |
Echevarria Zarate, Juan Ignacio |
|
dc.contributor.author |
Ruiz, Rosa |
|
dc.contributor.author |
Carrillo, Carlos |
|
dc.date.accessioned |
2022-10-10T00:48:55Z |
|
dc.date.available |
2022-10-10T00:48:55Z |
|
dc.date.issued |
1995 |
|
dc.identifier.uri |
https://hdl.handle.net/20.500.12866/12327 |
|
dc.description.abstract |
Since January 1991, cholera has emerged as a health problem in Latin AmericaJll The use of antimicrobial agents with recognised in vitro activity against Vibrio strains is recommended for treating severe forms of the disease. El Tor Vibrio cholerae 01, the pathogen responsible for this epidemic, has been sensitive to all the antimicrobial agents used... |
en_US |
dc.language.iso |
eng |
|
dc.publisher |
Springer |
|
dc.relation.ispartofseries |
Drugs |
|
dc.rights |
info:eu-repo/semantics/restrictedAccess |
|
dc.rights.uri |
https://creativecommons.org/licenses/by-nc-nd/4.0/deed.es |
|
dc.subject |
Quinolones |
en_US |
dc.subject |
Cholera |
en_US |
dc.subject |
Antimicrob Agent |
en_US |
dc.subject |
Typhoid Fever |
en_US |
dc.subject |
Shigellosis |
en_US |
dc.title |
Oral Ciprofloxacin in the Treatment of Cholera |
en_US |
dc.title.alternative |
Ciprofloxacina oral en el tratamiento del cólera |
es_PE |
dc.type |
info:eu-repo/semantics/article |
|
dc.identifier.doi |
https://doi.org/10.2165/00003495-199500492-00132 |
|
dc.subject.ocde |
https://purl.org/pe-repo/ocde/ford#3.01.06 |
|
dc.relation.issn |
1179-1950 |
|